CoChat

Neuroprotection with Angiotensin Receptor Antagonists: A Review of the Evidence and Potential Mechanisms

Wilms, Henrik, Rosenstiel, Philip, Unger, Thomas, Deuschl, G??nther, Lucius, Ralph · 2005 · American Journal of Cardiovascular Drugs

The DOI matches its Crossref record; 101 of the 102 references it cites were found in a registry or an index.

Abstract

The peptide hormone angiotensin (A)-II, the major effector peptide of the renin-angiotensin system (RAS), is well established to play a pivotal role in the systemic regulation of blood pressure, fluid, and electrolyte homeostasis. Recent biochemical and neurophysiologic studies have documented local intrinsic angiotensin-generating systems in organs and tissues such as the brain, retina, bone marrow, liver, and pancreas. The locally generated angiotensin peptides have multiple and novel actions including stimulating cell growth and anti-proliferative and/or antiapoptotic actions. In the mammalian brain, all components of the RAS are present including angiotensin receptor subtypes 1 (AT(1)) and 2 (AT(2)). A-II exerts most of its well defined physiologic and pathophysiologic actions, including those on the central and peripheral nervous system, through its AT(1) receptor subtype. While the AT(1) receptor is responsible for the classical effects of A-II, it has been found that the AT(2) receptor is linked to totally different signalling mechanisms and this has revealed hitherto unknown functions of A-II. AT(2) receptors are expressed at low density in many healthy adult tissues, but are upregulated in a variety of human diseases. This receptor not only contributes to stroke-related pathologic mechanisms (e.g. hypertension, atherothrombosis, and cardiac hypertrophy) but may also be involved in post-ischemic damage to the brain. It has been reported that the AT(2) receptor regulates several functions of nerve cells, e.g. ionic fluxes, cell differentiation, and neuronal tissue regeneration, and also modulates programmed cell death. In this article, we review the experimental evidence supporting the notion that blockade of brain AT(1) receptors can be beneficial with respect to stroke incidence and outcome. We further delineate how AT(2) receptors could be involved in neuronal regeneration following brain injury such as stroke or CNS trauma. The current review is focussed on some of the new functions arising from the locally formed A-II with particular attention to its emerging neuroprotective role in the brain.

Overview

Integrity signals

Registry

Crossref · 10.2165/00129784-200505040-00004

Cites

101 of 101 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 101 references

Research works printed but not linked: 6

  1. Dzau, 1994, J Hypertens Suppl, 12, S3
  2. Unger, 1996, J Hypertens Suppl, 14, S95
  3. Timmermans, 1993, Pharmacol Rev, 45, 205
  4. Stier, 1993, J Hypertens Suppl, 11, S37
  5. Balla, 1991, Mol Pharmacol, 40, 401
  6. Bertolino, 1994, J Pharmacol Exp Ther, 268, 747

Cited by

See all 52

Metadata

Authors
Wilms, H., Rosenstiel, P., Unger, T., Deuschl, G., & Lucius, R.
Affiliations
  • Christian-Albrechts-Universität zu Kiel (DE)
  • Humboldt-Universität zu Berlin (DE)
Corresponding author
Lucius, Ralph
Venue
American Journal of Cardiovascular Drugs
Published
2005
Volume
5
Issue
4
Pages
245-253
ISSN
1175-3277 (ISSN-L)
OpenAlex
W45749536
Cited by
52
References
102
Citations by year
2024: 2 · 2022: 3 · 2021: 5 · 2019: 4 · 2017: 2 · 2016: 2 · 2015: 4 · 2014: 3 · 2013: 2 · 2012: 6
FWCI
0.68
Type
journal article
Language
en
Open access
closed
Locations
  • American Journal of Cardiovascular Drugs (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
  • Life Sciences › Neuroscience › Neurology › Neuroprotection in Cerebral Ischemia
  • Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury and Neurovascular Disturbances
Keywords
angiotensin II, angiotensin receptor blockers, renin-angiotensin system, angiotensin II type 1 receptor, angiotensin II type 2 receptor, neuroprotection, stroke, brain injury, neuronal regeneration, apoptosis, cell proliferation, CNS trauma
MeSH terms
Animals, Brain Chemistry, Humans, Nerve Regeneration, Signal Transduction, Apoptosis, Neuroprotective Agents, Stroke, Receptor, Angiotensin, Type 1, Angiotensin II Type 1 Receptor Blockers

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Neuroprotection with Angiotensin Receptor Antagonists: A Review of the Evidence and Potential Mechanisms. https://app.cochat.ai/papers/10.2165/00129784-200505040-00004
The paper
Wilms, H., Rosenstiel, P., Unger, T., Deuschl, G., & Lucius, R. (2005). Neuroprotection with Angiotensin Receptor Antagonists: A Review of the Evidence and Potential Mechanisms. American Journal of Cardiovascular Drugs. https://doi.org/10.2165/00129784-200505040-00004

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.